Literature DB >> 20599361

Characteristics of clinical isolates of Acinetobacter genomospecies 10 carrying two different metallo-beta-lactamases.

Kyungwon Lee1, Chang Ki Kim, Seong Geun Hong, Jonghyeon Choi, Sungwook Song, Eunmi Koh, Dongeun Yong, Seok Hoon Jeong, Jong Hwa Yum, Jean-Denis Docquier, Gian Maria Rossolini, Yunsop Chong.   

Abstract

Acquired metallo-beta-lactamase (MBL) production is an important mechanism of carbapenem resistance. To our knowledge, carriage of two different MBLs has not been described previously in Acinetobacter spp. We present the characteristics of five Acinetobacter isolates carrying two different MBL genes. The species of all five Acinetobacter isolates with two different MBL genes were Acinetobacter genomospecies 10, and bla(IMP-1), bla(VIM-2) and bla(SIM-1) may coexist in this species. Minimum inhibitory concentrations (MICs) of imipenem for all five isolates with two different MBLs were >or=32 microg/mL, whilst those for two segregants that lost both MBLs were 0.5 microg/mL. The presence of MBL gene-carrying integrons with identical structures suggested the easily transferable nature of the elements, whilst instability of the MBL genes indicated potentially erroneous phenotypic and genetic characterisation. Copyright (c) 2010 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20599361     DOI: 10.1016/j.ijantimicag.2010.05.018

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  8 in total

1.  Clinical carbapenem-resistant Acinetobacter baylyi strain coharboring blaSIM-1 and blaOXA-23 from China.

Authors:  Zhihui Zhou; Xiaoxing Du; Li Wang; Qing Yang; Yiqi Fu; Yunsong Yu
Journal:  Antimicrob Agents Chemother       Date:  2011-08-29       Impact factor: 5.191

Review 2.  Double- and multi-carbapenemase-producers: the excessively armored bacilli of the current decade.

Authors:  G Meletis; D Chatzidimitriou; N Malisiovas
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-04-18       Impact factor: 3.267

3.  Biochemical and genetic characterization of carbapenem-hydrolyzing β-lactamase OXA-229 from Acinetobacter bereziniae.

Authors:  Rémy A Bonnin; Alain A Ocampo-Sosa; Laurent Poirel; Hélène Guet-Revillet; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2012-04-16       Impact factor: 5.191

4.  AbaR4-type resistance island including the blaOXA-23 gene in Acinetobacter nosocomialis isolates.

Authors:  Dae Hun Kim; Ji Young Choi; Sook-In Jung; Visanu Thamlikitkul; Jae-Hoon Song; Kwan Soo Ko
Journal:  Antimicrob Agents Chemother       Date:  2012-06-11       Impact factor: 5.191

5.  Characterization of the First Carbapenem-Resistant Pseudomonas aeruginosa Clinical Isolate Harboring blaSIM-1 from the United States.

Authors:  Catharine Prussing; Theresa Canulla; Navjot Singh; Patricia McAuley; Michael Gosciminski; Ewa King; Utpala Bandy; María-José Machado; Maria Karlsson; Kimberlee A Musser; Richard C Huard; Elizabeth J Nazarian
Journal:  Antimicrob Agents Chemother       Date:  2021-08-02       Impact factor: 5.191

6.  Draft Genome Sequence of Acinetobacter bereziniae HPC229, a Carbapenem-Resistant Clinical Strain from Argentina Harboring blaNDM-1.

Authors:  Marco Brovedan; Patricia M Marchiaro; Jorgelina Morán-Barrio; Santiago Revale; Marcela Cameranesi; Luciano Brambilla; Alejandro M Viale; Adriana S Limansky
Journal:  Genome Announc       Date:  2016-03-10

7.  Characterization of the diverse plasmid pool harbored by the blaNDM-1-containing Acinetobacter bereziniae HPC229 clinical strain.

Authors:  Marco Brovedan; Guillermo D Repizo; Patricia Marchiaro; Alejandro M Viale; Adriana Limansky
Journal:  PLoS One       Date:  2019-11-19       Impact factor: 3.240

8.  Detection of Antiseptic-Resistance Genes in Pseudomonas and Acinetobacter spp. Isolated From Burn Patients.

Authors:  Mohammadreza Mahzounieh; Sheida Khoshnood; Azizollah Ebrahimi; Saeid Habibian; Maryam Yaghoubian
Journal:  Jundishapur J Nat Pharm Prod       Date:  2014-04-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.